These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 29564387)

  • 1. New protein deposition tracers in the pipeline.
    Jovalekic A; Koglin N; Mueller A; Stephens AW
    EJNMMI Radiopharm Chem; 2017; 1(1):11. PubMed ID: 29564387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro characterization of [18F]-florbetaben, an Aβ imaging radiotracer.
    Fodero-Tavoletti MT; Brockschnieder D; Villemagne VL; Martin L; Connor AR; Thiele A; Berndt M; McLean CA; Krause S; Rowe CC; Masters CL; Dinkelborg L; Dyrks T; Cappai R
    Nucl Med Biol; 2012 Oct; 39(7):1042-8. PubMed ID: 22503458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular imaging of dementia.
    Mori T; Maeda J; Shimada H; Higuchi M; Shinotoh H; Ueno S; Suhara T
    Psychogeriatrics; 2012 Jun; 12(2):106-14. PubMed ID: 22712644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathological and Biomarker Findings in Parkinson's Disease and Alzheimer's Disease: From Protein Aggregates to Synaptic Dysfunction.
    Compta Y; Revesz T
    J Parkinsons Dis; 2021; 11(1):107-121. PubMed ID: 33325398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo tau PET imaging in dementia: Pathophysiology, radiotracer quantification, and a systematic review of clinical findings.
    Hall B; Mak E; Cervenka S; Aigbirhio FI; Rowe JB; O'Brien JT
    Ageing Res Rev; 2017 Jul; 36():50-63. PubMed ID: 28315409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of proteins related neurodegeneration in autopsy brains of the aged].
    Zhu M; Meng X; Wang L; Hu Y; Zhang H; Han Z
    Zhonghua Bing Li Xue Za Zhi; 2014 Oct; 43(10):651-6. PubMed ID: 25567589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small-molecule PET Tracers for Imaging Proteinopathies.
    Mathis CA; Lopresti BJ; Ikonomovic MD; Klunk WE
    Semin Nucl Med; 2017 Sep; 47(5):553-575. PubMed ID: 28826526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical Characterization of the Tau PET Tracer [
    Harada R; Lerdsirisuk P; Shimizu Y; Yokoyama Y; Du Y; Kudo K; Ezura M; Ishikawa Y; Iwata R; Shidahara M; Ishiki A; Kikuchi A; Hatano Y; Ishihara T; Onodera O; Iwasaki Y; Yoshida M; Taki Y; Arai H; Kudo Y; Yanai K; Furumoto S; Okamura N
    J Nucl Med; 2023 Sep; 64(9):1495-1501. PubMed ID: 37321821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large inter- and intra-case variability of first generation tau PET ligand binding in neurodegenerative dementias.
    Wren MC; Lashley T; Årstad E; Sander K
    Acta Neuropathol Commun; 2018 May; 6(1):34. PubMed ID: 29716656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted examination of amyloid beta and tau protein accumulation via positron emission tomography for the differential diagnosis of Alzheimer's disease based on the A/T(N) research framework.
    Wang Y; Zhang Y; Yu E
    Clin Neurol Neurosurg; 2024 Jan; 236():108071. PubMed ID: 38043158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations Between APOE Variants, Tau and α-Synuclein.
    Rodriguez-Vieitez E; Nielsen HM
    Adv Exp Med Biol; 2019; 1184():177-186. PubMed ID: 32096038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET Radiopharmaceuticals for Alzheimer's Disease and Parkinson's Disease Diagnosis, the Current and Future Landscape.
    Uzuegbunam BC; Librizzi D; Hooshyar Yousefi B
    Molecules; 2020 Feb; 25(4):. PubMed ID: 32098280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging Neuroinflammation: Quantification of Astrocytosis in a Multitracer PET Approach.
    Rodriguez-Vieitez E; Nordberg A
    Methods Mol Biol; 2018; 1750():231-251. PubMed ID: 29512077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Evaluation of 18F-PI-2620 as a Potent PET Radiotracer Imaging Tau Protein in Alzheimer Disease and Other Neurodegenerative Diseases Compared With 18F-THK-5351.
    Oh M; Oh SJ; Lee SJ; Oh JS; Roh JH; Chung SJ; Lee JH; Lee CS; Kim JS
    Clin Nucl Med; 2020 Nov; 45(11):841-847. PubMed ID: 32910050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant Overlap of α-Synuclein, Amyloid-β, and Phospho-Tau Pathologies in Neuropathological Diagnosis of Lewy-related Pathology: Evidence from China Human Brain Bank.
    Cong C; Zhang W; Qian X; Qiu W; Ma C
    J Alzheimers Dis; 2021; 80(1):447-458. PubMed ID: 33554920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in Brain Amyloid Imaging.
    Krishnadas N; Villemagne VL; Doré V; Rowe CC
    Semin Nucl Med; 2021 May; 51(3):241-252. PubMed ID: 33482999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro characterisation of BF227 binding to alpha-synuclein/Lewy bodies.
    Fodero-Tavoletti MT; Mulligan RS; Okamura N; Furumoto S; Rowe CC; Kudo Y; Masters CL; Cappai R; Yanai K; Villemagne VL
    Eur J Pharmacol; 2009 Sep; 617(1-3):54-8. PubMed ID: 19576880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid β, Tau, and α-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases.
    Sengupta U; Kayed R
    Prog Neurobiol; 2022 Jul; 214():102270. PubMed ID: 35447272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Sensitivity of Tau Tracers for the Discrimination of Alzheimer's Disease Patients and Healthy Controls by PET.
    Mohammadi Z; Alizadeh H; Marton J; Cumming P
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830659
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.